169 related articles for article (PubMed ID: 31037153)
1. Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.
von Knethen A; Schäfer A; Kuchler L; Knape T; Christen U; Hintermann E; Fißlthaler B; Schröder K; Brandes RP; Genz B; Abshagen K; Pützer BM; Sha LK; Weigert A; Syed SN; Schulz M; Shah AM; Ernst A; Putyrski M; Finkelmeier F; Pesic M; Greten F; Hogardt M; Kempf VAJ; Gunne S; Parnham MJ; Brüne B
Theranostics; 2019; 9(7):2003-2016. PubMed ID: 31037153
[TBL] [Abstract][Full Text] [Related]
2. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
Li W; Tu J; Liu X; Yang W
Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
[TBL] [Abstract][Full Text] [Related]
3. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis.
Hu YM; Hsiung YC; Pai MH; Yeh SL
JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555
[TBL] [Abstract][Full Text] [Related]
4. [Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis].
Huang J; Sun R; Qi X; Liu L; Yang Y; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1091-1096. PubMed ID: 31657331
[TBL] [Abstract][Full Text] [Related]
5. A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction.
Rossi AL; Le M; Chung CS; Chen Y; Fallon EA; Matoso A; Xu S; Chun TT; Erickson CP; Ayala A
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G106-G114. PubMed ID: 30431333
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction.
Zhang Y; Zhou Y; Lou J; Li J; Bo L; Zhu K; Wan X; Deng X; Cai Z
Crit Care; 2010; 14(6):R220. PubMed ID: 21118528
[TBL] [Abstract][Full Text] [Related]
8. MiR-142 inhibits cecal ligation and puncture (CLP)-induced inflammation via inhibiting PD-L1 expression in macrophages and improves survival in septic mice.
Zhen J; Chen W
Biomed Pharmacother; 2018 Jan; 97():1479-1485. PubMed ID: 29793310
[TBL] [Abstract][Full Text] [Related]
9. Activation of the peroxisome proliferator-activated receptor γ counteracts sepsis-induced T cell cytotoxicity toward alloantigenic target cells.
von Knethen A; Sha LK; Knape T; Kuchler L; Giegerich AK; Schulz M; Hauser IA; Brüne B
J Mol Med (Berl); 2015 Jun; 93(6):633-44. PubMed ID: 25559266
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effect of an Anti-Human Programmed Death-Ligand 1 (PD-L1) Nanobody on Polymicrobial Sepsis in Humanized Mice.
Zhao ZZ; Wang XL; Xie J; Chen LP; Li Q; Wang XX; Wang JF; Deng XM
Med Sci Monit; 2021 Jan; 27():e926820. PubMed ID: 33421049
[TBL] [Abstract][Full Text] [Related]
11. Novel Role for PD-1:PD-L1 as Mediator of Pulmonary Vascular Endothelial Cell Functions in Pathogenesis of Indirect ARDS in Mice.
Lomas-Neira J; Monaghan SF; Huang X; Fallon EA; Chung CS; Ayala A
Front Immunol; 2018; 9():3030. PubMed ID: 30619369
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model.
Zhu W; Bao R; Fan X; Tao T; Zhu J; Wang J; Li J; Bo L; Deng X
Mediators Inflamm; 2013; 2013():361501. PubMed ID: 24324295
[TBL] [Abstract][Full Text] [Related]
13. Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis.
Wang JF; Wang YP; Xie J; Zhao ZZ; Gupta S; Guo Y; Jia SH; Parodo J; Marshall JC; Deng XM
Blood; 2021 Sep; 138(9):806-810. PubMed ID: 34473230
[TBL] [Abstract][Full Text] [Related]
14. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy provides protective effects against CLP-induced sepsis by reducing TRegs and PD-1/PD-L1 expression.
Chen H; Huang N; Tian H; Li J; Li B; Sun J; Zhang S; Zhang C; Zhao Y; Kong G; Li Z
Int J Biochem Cell Biol; 2021 Jul; 136():105970. PubMed ID: 33774183
[TBL] [Abstract][Full Text] [Related]
16. Up-Regulation of Donor Dendritic Cell PD-L1 Expression Reduced Recipient Lymphocyte Activation and Proliferation In Vitro.
Li T; Ma R; Zhu JY
Transplant Proc; 2021 Mar; 53(2):716-723. PubMed ID: 33551184
[TBL] [Abstract][Full Text] [Related]
17. Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis.
Zhou J; Peng H; Li K; Qu K; Wang B; Wu Y; Ye L; Dong Z; Wei H; Sun R; Tian Z
Immunity; 2019 Feb; 50(2):403-417.e4. PubMed ID: 30709740
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of hepatic cytochrome P-450 isoforms and PPAR-gamma: their role in hepatic injury and proinflammatory responses in a double-hit model of hemorrhage and sepsis.
Higuchi S; Wu R; Zhou M; Ravikumar TS; Wang P
J Surg Res; 2007 Jan; 137(1):46-52. PubMed ID: 17101152
[TBL] [Abstract][Full Text] [Related]
19. Reactive glia promote development of CD103
Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
[TBL] [Abstract][Full Text] [Related]
20. Oxygen Saturation on Admission Is a Predictive Biomarker for PD-L1 Expression on Circulating Monocytes and Impaired Immune Response in Patients With Sepsis.
Avendaño-Ortiz J; Maroun-Eid C; Martín-Quirós A; Lozano-Rodríguez R; Llanos-González E; Toledano V; Gómez-Campelo P; Montalbán-Hernández K; Carballo-Cardona C; Aguirre LA; López-Collazo E
Front Immunol; 2018; 9():2008. PubMed ID: 30233593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]